Konishi E, Fujii A, Mason P W
Department of Health Sciences, Kobe University School of Medicine, Kobe 654-0142, Japan.
J Virol. 2001 Mar;75(5):2204-12. doi: 10.1128/JVI.75.5.2204-2212.2001.
We have generated a cell line (F cells) producing a secreted form of Japanese encephalitis virus (JEV) subviral particle (extracellular particles [EPs]) that contains the JEV envelope glycoprotein (E) and a precursor (prM) of the virion membrane protein (M). The F cells were engineered to synthesize these JEV products from a cDNA encoding a mutated (furin proteinase resistant) form of prM, since stable cell lines expressing E and the authentic form of prM could not be obtained, due (in part) to the cell-fusing ability of EPs containing E and M. Our biochemical alteration of the prM protein was critical for the successful production of EP-producing cell lines. EPs produced by F cells share the biochemical properties of empty viral particles produced by JEV-infected cells, except that the F-cell EPs lack hemagglutinating activity and M. F-cell EPs were recognized by a panel of monoclonal antibodies to E, and EPs were shown to be useful as vaccine candidates in mice and as diagnostic reagents in evaluating human immune responses to JE vaccination. The amounts of E antigen released into the culture fluid of F cells were similar to those found in virion fractions of JEV-infected cell culture fluids or JEV-infected weanling mouse brains (the current source of antigen used to produce human vaccines for JE). Thus, the F-cell line would appear to be a useful source of antigen for JE vaccines and diagnostics.
我们已构建出一种细胞系(F细胞),其可产生分泌形式的日本脑炎病毒(JEV)亚病毒颗粒(细胞外颗粒[EP]),该颗粒包含JEV包膜糖蛋白(E)和病毒体膜蛋白(M)的前体(prM)。由于(部分)含有E和M的EP具有细胞融合能力,无法获得稳定表达E和prM真实形式的细胞系,因此对F细胞进行基因工程改造,使其从编码prM突变形式(抗弗林蛋白酶)的cDNA合成这些JEV产物。我们对prM蛋白进行的生化改造对于成功构建产生EP的细胞系至关重要。F细胞产生的EP具有与JEV感染细胞产生的空病毒颗粒相同的生化特性,只是F细胞的EP缺乏血凝活性且不含M。一组针对E的单克隆抗体可识别F细胞的EP,并且已证明EP可用作小鼠疫苗候选物以及评估人类对JE疫苗免疫反应的诊断试剂。释放到F细胞培养液中的E抗原量与JEV感染细胞培养液或JEV感染的断奶小鼠脑(目前用于生产人用JE疫苗的抗原来源)的病毒体组分中的量相似。因此,F细胞系似乎是用于JE疫苗和诊断的有用抗原来源。